• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 7, Issue 8
  3. Author

Online ISSN: 2515-8260

Volume7, Issue8

Pharmacokinetic Profiling of Moxifloxacin Gastroretentive Drug Delivery System after Oral Administration

    Yogesh Gurav, Adhikrao Yadav, Fahim J. Sayyad, Suresh Sudke

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 8, Pages 5052-5063

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

In the present investigation, we have designed a gastroretentive drug delivery system of moxifloxacin for the pharmacokinetic profiling of this system by relating it with moxifloxacin controlled release drug delivery system. A fast, simple, precise, specific and sensitive high performance liquid chromatography (HPLC)-ultraviolet-visible (UV) method was developed and validated for the plasma sample analysis. The C18 column was deployed for moxifloxacin separation using the mixture of acetonitrile and 0.5% triethylamine solution. The calibration curve was linear for concentration range of 10–1000 µg/L. A pharmacokinetic study was performed using oral single dose of 5 mg/kg moxifloxacin in healthy white New Zealand rabbits (n = 6) by administrating gastroretentive and controlled release systems respectively. One compartment open model was applied for the estimation of pharmacokinetic parameters after oral administration. The controlled release system of moxifloxacin shows significantly lower value average steady state plasma concentration (884.33±5.27 µg/L) than gastroretentive system (1389.67±11.31 µg/L). The quick attainment of steady state level of drug in plasma indicates higher value absorption rate constant and lower absorption half-life for gastroretentive system. The area under curve for controlled and gastroretentive system were found to be 9.57±0.53 and 27.34±1.32 mg.h/L respectively. The results concluded that gastroretentive system have 2.86 folds greater relative bioavailability and double value of mean residence time in comparison to controlled release system.
Keywords:
  • PDF (293 K)
  • XML
(2021). Pharmacokinetic Profiling of Moxifloxacin Gastroretentive Drug Delivery System after Oral Administration. European Journal of Molecular & Clinical Medicine, 7(8), 5052-5063.
Yogesh Gurav, Adhikrao Yadav, Fahim J. Sayyad, Suresh Sudke. "Pharmacokinetic Profiling of Moxifloxacin Gastroretentive Drug Delivery System after Oral Administration". European Journal of Molecular & Clinical Medicine, 7, 8, 2021, 5052-5063.
(2021). 'Pharmacokinetic Profiling of Moxifloxacin Gastroretentive Drug Delivery System after Oral Administration', European Journal of Molecular & Clinical Medicine, 7(8), pp. 5052-5063.
Pharmacokinetic Profiling of Moxifloxacin Gastroretentive Drug Delivery System after Oral Administration. European Journal of Molecular & Clinical Medicine, 2021; 7(8): 5052-5063.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 28
  • PDF Download: 41
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  info@ejmcm.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

Editorial Team:  editor@ejmcm.com

For Special Issue Proposal : chiefeditor.ejmcm@gmail.com / info@ejmcm.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus